Markets

Clovis Oncology (CLVS) in Focus: Stock Moves 5.6% Higher

Clovis Oncology, Inc.CLVS was a big mover last session, as the company saw its shares rise above 5% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up almost 37% in the past one-month time frame.

In the last 30 days, the company has seen no estimate revision and the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Clovis Oncology currently carries a Zacks Rank # 3 (Hold) while its Earnings ESP is 0.00%.

Clovis Oncology, Inc. Price

Clovis Oncology, Inc. Price | Clovis Oncology, Inc. Quote

Another well-ranked Medical-Biomedical and Genetics stock is Enzo Biochem, Inc. ENZ , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .

Is CLVS going up? Or down? Predict to see what others think: Up or Down

The Best Place to Start Your Stock Search

Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buy" stocks - absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 "Strong Sells" and other private research. See these stocks free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Enzo Biochem, Inc. (ENZ): Free Stock Analysis Report

Clovis Oncology, Inc. (CLVS): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CLVS ENZ

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More